Duration of hepatitis C virus (HCV) infection is a key feature in dete
rmining responsiveness to interferon (IFN). Studies assessing its valu
e as a predictive factor in chronic HCV infection show that a long dur
ation of infection reduces the likelihood of a sustained response to I
FN (defined as ALT normalization and clearance of serum HCV-RNA). The
effect of HCV infection duration is independent of the presence of cir
rhosis and level of HCV viremia. Meta-analysis of IFN trials in acute
HCV infection shows an obvious effect of the drug on long-term ALT nor
malization and HCV-RNA clearance. Treatment of HCV infection during th
e acute or early chronic phase could therefore maximize therapeutic ef
fectiveness.